Govt caps trade margin on oxygen concentrators at 70%
NPPA caps trade margins on oxygen concentrators at 70% to curb price spikes; MTaI welcomes move as step toward affordability.
Read More
If priority products are zero rated, it would be a true removal of GST from the entire value chain: Sanjay Bhutani
Experts say GST exemption can raise costs; zero-rating COVID supplies would cut prices by allowing input tax credits across the supply chain.
Read More
Public Procurement Policies Must Not Deprive Patients Their Access To Innovative And Quality Medical Devices
MTaI warns revised Public Procurement Order may limit patient access, deter investment, and needs deeper consultation on local capacity.
Read More
Govt orders to prefer local medical devices, cut imports by Rs 4,000 crore
MTaI criticises revised PPO as poorly analysed and regressive, warning it may hurt FDI, patient access, and MedTech innovation.
Read More
Medical technology sector likely to recover to pre-COVID levels by July-December 2021: MTaI
MTaI says MedTech may recover only by late 2021, hit by COVID, high import costs, rupee fall, and unnuanced policies hurting viability.
Read More
Interpretation of Aatma Nirbhar Bharat in MedTech sector: MTaI
MTaI says MedTech self-reliance means competitive Make-in-India devices, strong R&D, Heal in India, skilled workforce, and renewed FDI.
Read More
Resumption of elective surgeries required to soften COVID-19 blow to healthcare sector: MTaI
MTaI urges early resumption of elective surgeries, saying prolonged shutdowns are crippling hospital revenues and disrupting the healthcare supply chain.
Read More
Need to carve concrete plan on building healthcare infrastructure at tertiary levels in government, private sectors: MTaI
MTaI urges higher healthcare spending, fiscal relief, tax cuts on devices, clearance of dues, and safe restart of elective surgeries to sustain the sector.
Read More
Persistent financial, logistical bottlenecks creating operational challenges for medical device sector: MTaI
MTaI warns COVID-era cash crunch, logistics issues hit MedTech supply; seeks dues release, tax relief, health cess rollback, and zero-interest loans.
Read More